Paul Hudson

Paul Hudson

executive France

Paul Hudson is the Chief Executive Officer of Sanofi, a global biopharmaceutical company. Under his leadership, Sanofi has made significant investments in China, particularly in biopharmaceutical manufacturing and innovation, including a recent €1 billion investment to expand its production capacity in the Beijing Economic-Technological Development Area. Hudson's commitment to enhancing healthcare solutions aligns with the growing demand for diabetes treatments and advanced medical technologies.

Born on Jan 01, 1967 (58 years old)

Global Media Ratings
Dominance
0.05%
Persistence
1 wks
Reach
4,586,376
Power
46,217$
Sentiment
8.15
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
China 6 8.17 0.30% +10% 1,402,112,000 4,560,837 $14,000,000 45,540$
Taiwan 1 7.00 0.10% +0% 23,816,775 23,675 $670,000 666$
North Macedonia 1 8.00 0.09% +0% 2,083,374 1,863 $12,800 11$
Totals 8 1,428,012,149 4,586,375 $14,682,800 46,217$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

China China: Paul Hudson, the CEO of Sanofi, announced a significant investment in a new insulin production facility in Beijing, marking a major milestone for the company in China. 9

People's Daily: “我们对中国市场充满信心” --国际--人民网

China China: Paul Hudson emphasized the importance of high standards and sustainability in the new Sanofi production base. 8

People's Daily: 从外资大项目看引资新变化 --经济·科技--人民网